Research / ARDX / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-22-021047 General Corporate
Debt relative to revenue 27th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
1044.06% · OPTIONAL · VALID
Capex intensity 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 63th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1238.36% · OPTIONAL · VALID
Revenue growth 67th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
92.38% · CORE · VALID
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
179.30% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating margin 71th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-1037.81% · CORE · VALID
R&D intensity 18th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
385.63% · OPTIONAL · VALID
SBC intensity 29th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
126.41% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 7/8 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 5585.26%
Current 1044.06%
Delta -4541.19% Cash Generation Increased
Previous -5901.71%
Current -1238.36%
Delta 4663.35% Growth Increased
Previous -92.89%
Current 92.38%
Delta 185.27% Inventory Pressure Decreased
Previous 745.09%
Current 179.30%
Delta -565.79% Profitability Increased
Previous -5941.67%
Current -1037.81%
Delta 4903.86% R And D Intensity Decreased
Previous 1891.24%
Current 385.63%
Delta -1505.61% Sbc Intensity Decreased
Previous 795.30%
Current 126.41%
Delta -668.89% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.